跳至主要内容
临床试验/JPRN-UMIN000003201
JPRN-UMIN000003201已完成2 期

A phase II study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma - chemoradiation therapy for advanced or recurrent gastric adenocarcinoma

Study group of multi-modality therapy for gastric cancer0 个研究点目标入组 5 人开始时间: 2010年2月17日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
5

研究概览

简要总结

This trial was terminated, because sufficient number of patients enrolled.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Tumor localization is not detected by neither CT, endoscopy nor upper GI series 2) Serious comorbidities 3) Severe GI obstruction or gastrointestinal bleeding 4) Current inflammation or acute inflammatory disease 5) Allergy to cremophor EL 6) Brain metastasis with symptom 7) Female with present pregnancy or breast-feeding, or contemplating pregnancy. 8) Registered to other clinical trial 9) Patients judged inappropriate for the study by the physicians

研究者

发起方
Study group of multi-modality therapy for gastric cancer

相似试验